BlackRock Group’s Insmed INSM Stock Holding History

BlackRock Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$384K	Buy	29,032 +2,351	+9%	+$32.1K	﹤0.01%	2438
2016 Q3	$387K	Buy	26,681 +1,008	+4%	+$12.6K	﹤0.01%	2397
2016 Q2	$253K	Sell	25,673 -336	-1%	-$3.92K	﹤0.01%	2489
2016 Q1	$330K	Buy	26,009 +7,439	+40%	+$97.8K	﹤0.01%	2396
2015 Q4	$336K	Sell	18,570 -450	-2%	-$7.93K	﹤0.01%	2354
2015 Q3	$354K	Buy	19,020 +3,288	+21%	+$82.1K	﹤0.01%	2333
2015 Q2	$384K	Buy	15,732 +9,957	+172%	+$226K	﹤0.01%	2360
2015 Q1	$120K	Buy	5,775 +971	+20%	+$17.1K	﹤0.01%	2619
2014 Q4	$75K	Buy	4,804 +3,735	+349%	+$53K	﹤0.01%	2719
2014 Q3	$14K	Buy	+1,069	New	+$16.1K	﹤0.01%	2780
2014 Q2	–	Sell	-4,782	Closed	-$91K	–	2841
2014 Q1	$91K	Buy	+4,782	New	+$90.9K	﹤0.01%	2580

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Group's INSM Position: Q4 2016 in Review

BlackRock Group increased its Insmed (INSM) stake by 8.8% in Q4 2016, buying an estimated $32.1K and bringing the position to 29,032 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #2438.

BlackRock Group first reported a position in INSM in Q1 2014 and has held it in 11 quarters since. The position peaked at $387K in Q3 2016. 101 funds tracked by Wall St. Rank hold INSM as of Q4 2016.

BlackRock Group held 29,032 shares of Insmed worth $384K as of Q4 2016.
BlackRock Group bought 2,351 Insmed shares in Q4 2016, an estimated $32.1K.
Insmed made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2438 holding.
BlackRock Group first reported a position in Insmed in Q1 2014 and has held it in 11 quarters since.
BlackRock Group's Insmed position peaked at $387K in Q3 2016.
101 funds tracked by Wall St. Rank held Insmed as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.